English
Home > Products > CAS NO 52549-17-4

China CAS NO 52549-17-4 Factory

We try for excellence, service the customers", hopes to be the most effective cooperation workforce and dominator company for staff, suppliers and shoppers, realizes price share and ongoing marketing for CAS NO 52549-17-4,52549-17-4,Pranoprofen API,Pranoprofen, Welcome any within your inquiries and concerns for our products and solutions, we glance ahead to setting up a long-term enterprise partnership along with you within the close to potential. get hold of us today.
CAS NO 52549-17-4, Our factory insists on the principle of "Quality First, Sustainable Development", and takes "Honest Business, Mutual Benefits" as our developable goal. All members sincerely thanks for all old and new customers' support. We are going to keep working hard and offering you the highest-quality products and solutions and service.Thanks.

Related Products

Hot Products

  • (S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol

    (S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol

    Product Name:(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol
    Molecular Formula:C10H8F6O
    Molecular Weight:258.16
    CAS Registry Number:225920-05-8
  • 10-Deacetylbaccatin III

    10-Deacetylbaccatin III

    Product Name:10-Deacetylbaccatin III
    Molecular Formula:C29H36O10
    Molecular Weight:544.59
    CAS Registry Number:32981-86-5
  • (5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone

    (5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone

    Product Name:(5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone CAS NO:461432-22-4
    Molecular Formula:C15H12BrClO2
    Formula Weight:339.61
    Usage:Dapagliflozin Intermediates​
  • Dihydroproscar

    Dihydroproscar

    Product Name:Dihydroproscar
    Molecular Formula:C23H38N2O2
    Molecular Weight:374.56
    CAS Registry Number:98319-24-5
  • Almagate

    Almagate

    Product Name:Almagate
    Molecular Formula:CH6AlMgO4(-3)
    Molecular Weight;133.34
    CAS Registry Number;66827-12-1
  • 4-Chlorophenethylalcohol

    4-Chlorophenethylalcohol

    Product Name:4-Chlorophenethylalcohol
    Molecular Formula:C8H9ClO
    Molecular Weight:156.61
    CAS Registry Number:1875-88-3
  • Related Blog
  • Reviews

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept